TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
NVAX

Novavax Inc

Healthcare · Biotechnology

12.60$ +20.1% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

Novavax Inc (NVAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 57 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement NVAX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
3.2 5.4 5.7 6.7 8.4 10 9.7 11 7.7 6.1 4.0 3.4 2.5 8.8 3.4 36 157 280 447 298 179 -727 605 186 735 288 -6.4 424 22 291 94 415 85 88 667 239 70 147 140 57 414
64 51 44 46 46 50 45 45 41 43 35 30 19 29 – – – – – – – 3.7 15 271 435 182 34 56 99 149 49 46 61 37 14 14 21 25 31 14 92
3.2 -46 5.7 6.7 8.4 -39 9.7 11 7.7 6.1 4.0 3.4 2.5 8.8 3.4 36 157 280 447 298 179 -727 589 -85 300 106 -41 369 -77 142 45 369 24 52 653 225 49 122 109 42 322
53 51 38 39 42 50 45 45 41 43 35 30 19 29 17 35 294 401 593 571 408 963 383 290 304 258 247 219 106 165 93 107 87 104 89 78 98 74 95 71 338
14 8.3 8.9 8.9 8.1 8.5 8.7 8.2 8.3 9.2 8.7 9.6 7.9 8.2 9.4 18 57 61 63 73 78 84 96 108 123 327 113 94 107 155 87 101 71 78 48 44 32 34 29 27 121
67 59 47 48 50 58 53 53 50 53 44 40 27 38 26 53 351 463 656 644 486 98 380 398 427 350 272 313 49 326 184 208 158 183 137 119 227 101 124 97 549
-63 -54 -41 -41 -42 -48 -44 -42 -42 -47 -40 -37 -15 -29 -23 -17 -194 -183 -209 -346 -307 -825 209 -483 -127 -244 -313 55 -126 -184 -139 161 -134 -131 516 106 -178 21 -15 -55 -227
3.5 3.5 3.5 3.5 3.5 3.5 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.4 3.4 3.4 4.5 3.9 4.8 6.0 5.2 5.1 4.9 6.2 4.2 4.6 4.3 3.1 2.9 4.1 4.1 4.1 4.2 7.6 5.7 5.5 5.5 5.8 4.9 5.7 22
-66 -57 -44 -44 -45 -51 -46 -44 -45 -49 -43 -40 -18 -32 -26 -18 -197 -178 -220 -349 -316 -830 206 -509 -166 -185 -293 58 -131 -177 -145 165 -122 -74 520 107 -203 18 -8.5 -52 -245
3.5 0.8 3.5 3.5 3.5 1.0 3.1 3.1 3.0 0.8 3.0 3.0 -6.8 2.2 3.0 5.7 5.1 1.9 3.0 3.5 6.0 17 2.7 1.4 2.5 -2.3 1.2 -0.1 -0.7 1.7 2.3 2.2 -1.0 7.4 1.2 0.9 -0.7 0.4 1.0 1.7 2.4
-66 -57 -44 -44 -45 -51 -46 -44 -45 -49 -43 -40 -18 -32 -26 -18 -197 -178 -223 -352 -322 -846 203 -510 -169 -182 -294 58 -131 -178 -148 162 -121 -81 519 107 -202 18 -9.5 -53 -248
-61 -51 -38 -39 -38 -45 -41 -39 -39 -44 -38 -35 -14 -28 -22 -13 -192 -171 -213 -340 -307 -821 218 -496 -154 -172 -279 71 -117 -162 -129 180 -105 -53 534 121 -191 29 -0.5 -40 -203

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?